Luminescent conjugated oligothiophenes distinguish between α-synuclein assemblies of Parkinson’s disease and multiple system atrophy

被引:0
作者
Therése Klingstedt
Bernardino Ghetti
Janice L. Holton
Helen Ling
K. Peter R. Nilsson
Michel Goedert
机构
[1] MRC Laboratory of Molecular Biology,Department of Pathology and Laboratory Medicine
[2] Indiana University School of Medicine,Department of Physics, Chemistry and Biology
[3] Queen Square Brain Bank,undefined
[4] UCL Queen Square Institute of Neurology,undefined
[5] Linköping University,undefined
来源
Acta Neuropathologica Communications | / 7卷
关键词
α-Synuclein; Luminescent conjugated oligothiophene; Multiple system atrophy; Neurodegeneration; Parkinson’s disease; Spectral analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Synucleinopathies [Parkinson’s disease with or without dementia, dementia with Lewy bodies and multiple system atrophy] are neurodegenerative diseases that are defined by the presence of filamentous α-synuclein inclusions. We investigated the ability of luminescent conjugated oligothiophenes to stain the inclusions of Parkinson’s disease and multiple system atrophy. They stained the Lewy pathology of Parkinson’s disease and the glial cytoplasmic inclusions of multiple system atrophy. Spectral analysis of HS-68-stained inclusions showed a red shift in multiple system atrophy, but the difference with Parkinson’s disease was not significant. However, when inclusions were double-labelled for HS-68 and an antibody specific for α-synuclein phosphorylated at S129, they could be distinguished based on colour shifts with blue designated for Parkinson’s disease and red for multiple system atrophy. The inclusions of Parkinson’s disease and multiple system atrophy could also be distinguished using fluorescence lifetime imaging. These findings are consistent with the presence of distinct conformers of assembled α-synuclein in Parkinson’s disease and multiple system atrophy.
引用
收藏
相关论文
共 210 条
[1]  
Goedert M(2017)The Synucleinopathies: twenty years on J Park Dis 7 S51-S69
[2]  
Jakes R(1992)Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181-184
[3]  
Spillantini MG(1997)α-Synuclein in Lewy bodies Nature 388 839-840
[4]  
Hughes AJ(2006)Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease J Biol Chem 281 29739-29752
[5]  
Daniel SE(2002)α-Synuclein is phosphorylated in synucleinopathy lesions Nat Cell Biol 4 160-164
[6]  
Kilford L(1998)Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies Neurosci Lett 251 205-208
[7]  
Lees AJ(1998)Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein Ann Neurol 44 415-422
[8]  
Spillantini MG(1998)α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci Lett 249 180-182
[9]  
Schmidt ML(2017)Alzheimer’s disease-related dementias summit 2016: national research priorities Neurology 89 2381-2391
[10]  
Lee VMY(2015)Multiple system atrophy N Engl J Med 372 249-263